Technical Analysis for KAPA - Kairos Pharma, Ltd.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.53 | -2.22% | -0.03 |
KAPA closed down 4.29 percent on Thursday, January 23, 2025, on 6 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | -2.22% | |
| Fell Below 50 DMA | Bearish | -2.22% | |
| NR7 | Range Contraction | -2.22% | |
| NR7-2 | Range Contraction | -2.22% | |
| Narrow Range Bar | Range Contraction | -2.22% | |
| Wide Bands | Range Expansion | -2.22% | |
| 20 DMA Support | Bullish | -6.42% | |
| Crossed Above 50 DMA | Bullish | -6.42% | |
| NR7 | Range Contraction | -6.42% | |
| Narrow Range Bar | Range Contraction | -6.42% |
| Alert | Time |
|---|---|
| 50 DMA Resistance | about 1 hour ago |
| 20 DMA Resistance | about 1 hour ago |
| Up 5% | about 1 hour ago |
| Up 3% | about 1 hour ago |
| Down 1% | about 1 hour ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
- Earnings date: Unknown
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immunotherapies Drug Therapies
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immunotherapies Drug Therapies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.0 |
| 52 Week Low | 0.885 |
| Average Volume | 2,730,599 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 1.60 |
| 20-Day Moving Average | 1.56 |
| 10-Day Moving Average | 1.52 |
| Average True Range | 0.37 |
| RSI (14) | 49.75 |
| ADX | 32.91 |
| +DI | 35.05 |
| -DI | 14.61 |
| Chandelier Exit (Long, 3 ATRs) | 2.15 |
| Chandelier Exit (Short, 3 ATRs) | 1.98 |
| Upper Bollinger Bands | 2.05 |
| Lower Bollinger Band | 1.08 |
| Percent B (%b) | 0.5 |
| BandWidth | 61.93 |
| MACD Line | 0.00 |
| MACD Signal Line | -0.01 |
| MACD Histogram | 0.0138 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.74 | ||||
| Resistance 3 (R3) | 1.75 | 1.69 | 1.71 | ||
| Resistance 2 (R2) | 1.69 | 1.65 | 1.69 | 1.70 | |
| Resistance 1 (R1) | 1.63 | 1.62 | 1.62 | 1.62 | 1.69 |
| Pivot Point | 1.57 | 1.57 | 1.57 | 1.57 | 1.57 |
| Support 1 (S1) | 1.51 | 1.53 | 1.50 | 1.50 | 1.43 |
| Support 2 (S2) | 1.45 | 1.50 | 1.45 | 1.42 | |
| Support 3 (S3) | 1.39 | 1.45 | 1.41 | ||
| Support 4 (S4) | 1.38 |
